Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
CGONCG Oncology	$3.49bn	n/a	n/a
XENEXenon Pharmaceuticals	$3.48bn	n/a	n/a
RCUSArcus Biosciences	$3.48bn	n/a	n/a
IDYAIdeaya Biosciences	$3.14bn	n/a	n/a
TVTXTravere Therapeutics	$3.13bn	n/a	n/a
VRDNViridian Therapeutics	$3.06bn	n/a	n/a
FOLDAmicus Therapeutics	$3.05bn	n/a	n/a
MLYSMineralys Therapeutics	$3.05bn	n/a	n/a
NUVBNuvation Bio	$2.93bn	n/a	n/a
DNLIDenali Therapeutics	$2.93bn	n/a	n/a
KDNYChinook Therapeutics	$2.90bn	n/a	n/a
DYNDyne Therapeutics	$2.90bn	n/a	n/a
VERAVera Therapeutics	$2.87bn	n/a	n/a
MORFMorphic Holding	$2.86bn	n/a	n/a
SLNOSoleno Therapeutics	$2.76bn	n/a	n/a
BEAMBeam Therapeutics	$2.75bn	n/a	n/a
TERNTerns Pharmaceuticals	$2.64bn	n/a	n/a
SYRESpyre Therapeutics	$2.60bn	n/a	n/a
EWTXEdgewise Therapeutics	$2.50bn	n/a	n/a
RXRXRecursion Pharmaceuticals	$2.45bn	n/a	n/a